Head-to-head · free

Quanome Technologies, Inc. vs Rentokil Initial

QNME vs RTO — return on capital, cash generation, margins and balance sheet side by side.

QNME

1 / 3

measures where QNME leads

RTO

2 / 3

measures where RTO leads

A simple count of which company scores better on each measure — not a recommendation to buy or sell.

MeasureQNME · FY2026RTO
Revenue$5.9M—
Net income(9.5M)—
Revenue growth (yearly, multi-year)-68.1%—
Free cash flow——
Free cash flow margin——
Net cash / (debt)——
ROIC—3.9%
Return on equity—8.7%
Gross margin56.7%83.1%
Operating margin-125.0%9.5%
Net debt / EBITDA0.03x2.83x

Figures are as reported by each company; latest fiscal year shown.

Where Quanome Technologies, Inc.'s cash went (FY2026)

Capital spending
$2048
Buybacks
—
Dividends
—
Acquisitions
—
Net debt issued / (repaid)
—
Full QNME profile →

Where Rentokil Initial's cash went

Not reported yet.

Full RTO profile →

Ask which business is stronger

"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.

Compare them free

More comparisons